Antikoagulation und Gerinnungsstörungen in der Schwangerschaft
- 12 June 2008
- journal article
- abstracts
- Published by Springer Nature in Die Innere Medizin
- Vol. 49 (7) , 779-787
Abstract
A review of coagulation disturbances during pregnancy and the current management of the anticoagulated patient with heart valve prostheses, atrial fibrillation, and thromboembolic events is presented. All patients with mechanical heart valve prostheses require life-long oral anticoagulation with coumarin or one of its derivatives. Recommendations for the treatment and prevention of thromboembolic events are discussed. The advantages and disadvantages of three different treatment approaches to anticoagulation during pregnancy are discussed and recommendations for the management in different situations are outlined with delineation of specific risks for the mother and the fetus.Keywords
This publication has 42 references indexed in Scilit:
- Thrombophilias and adverse pregnancy outcome – A confounded problem!Thrombosis and Haemostasis, 2008
- Fibrinolytic Defects and Recurrent MiscarriageObstetrics & Gynecology, 2007
- Pregnancy Failure and Heritable ThrombophiliaSeminars in Hematology, 2007
- Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant womenThrombosis and Haemostasis, 2007
- ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial FibrillationCirculation, 2006
- Vitamin K antagonists and pregnancy outcomeThrombosis and Haemostasis, 2006
- A prospective trial that demonstrates that dalteparin requirements increase in pregnancy to maintain therapeutic levels of anticoagulationAmerican Journal of Obstetrics and Gynecology, 2004
- Low molecular weight heparin for the prophylaxis of thromboembolism in women with prosthetic mechanical heart valves during pregnancyThrombosis and Haemostasis, 2004
- Coumarin derivatives and breast-feedingObstetrics & Gynecology, 2000
- Is warfarin sodium contraindicated in the lactating mother?The Journal of Pediatrics, 1983